Drug Type mRNA |
Synonyms H2009.08.qX.Y.Z.930 |
Target |
Action modulators |
Mechanism MYC modulators(Myc proto-oncogene protein modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-Small Cell Lung Cancer | Preclinical | United States | 05 Jul 2022 |